Massachusetts Financial Services CO Maravai Lifesciences Holdings, Inc. Transaction History

Massachusetts Financial Services CO

$296 Billion
Q2 2025

A detailed history of Massachusetts Financial Services CO transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 16,922 shares of MRVI stock, worth $45,520. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,922

Previous 247,821 93.17%

Holding current value

$45,520

Previous $547,000 92.69%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$1.72 - $2.47 $397,146 - $570,320	-230,899 Reduced 93.17%	16,922 $40,000
Q1 2025 May 02, 2025	SELL	$2.21 - $6.13 $9.76 Million - $27.1 Million	-4,416,389 Reduced 94.69%	247,821 $547,000
Q4 2024 Feb 12, 2025	BUY	$4.42 - $8.5 $4.7 Million - $9.03 Million	1,062,485 Added 29.5%	4,664,210 $25.4 Million
Q3 2024 Nov 12, 2024	SELL	$6.84 - $9.73 $6.49 Million - $9.23 Million	-948,778 Reduced 20.85%	3,601,725 $29.9 Million
Q2 2024 Aug 09, 2024	BUY	$6.87 - $11.34 $4.11 Million - $6.79 Million	598,530 Added 15.15%	4,550,503 $32.6 Million
Q1 2024 May 14, 2024	SELL	$5.11 - $8.76 $10.5 Million - $18.1 Million	-2,062,602 Reduced 34.29%	3,951,973 $34.3 Million
Q4 2023 Feb 08, 2024	SELL	$4.7 - $9.87 $10.1 Million - $21.1 Million	-2,138,905 Reduced 26.23%	6,014,575 $39.4 Million
Q3 2023 Nov 08, 2023	SELL	$9.14 - $12.85 $27.4 Million - $38.6 Million	-3,000,776 Reduced 26.9%	8,153,480 $81.5 Million
Q2 2023 Aug 09, 2023	SELL	$12.09 - $15.0 $7.29 Million - $9.05 Million	-603,231 Reduced 5.13%	11,154,256 $139 Million
Q1 2023 May 10, 2023	SELL	$12.99 - $16.48 $16.8 Million - $21.3 Million	-1,290,473 Reduced 9.89%	11,757,487 $165 Million
Q4 2022 Feb 13, 2023	SELL	$12.5 - $24.78 $13.8 Million - $27.3 Million	-1,102,931 Reduced 7.79%	13,047,960 $187 Million
Q3 2022 Nov 09, 2022	BUY	$20.6 - $30.37 $30.1 Million - $44.3 Million	1,459,720 Added 11.5%	14,150,891 $361 Million
Q2 2022 Aug 09, 2022	BUY	$26.05 - $37.48 $97.1 Million - $140 Million	3,726,068 Added 41.56%	12,691,171 $361 Million
Q1 2022 May 11, 2022	BUY	$24.46 - $40.92 $23.5 Million - $39.4 Million	962,082 Added 12.02%	8,965,103 $316 Million
Q4 2021 Feb 10, 2022	BUY	$35.0 - $45.94 $86.1 Million - $113 Million	2,459,692 Added 44.37%	8,003,021 $335 Million
Q3 2021 Nov 10, 2021	BUY	$36.8 - $60.62 $19.3 Million - $31.8 Million	523,916 Added 10.44%	5,543,329 $272 Million
Q2 2021 Aug 13, 2021	SELL	$32.46 - $45.0 $11.8 Million - $16.4 Million	-363,705 Reduced 6.76%	5,019,413 $209 Million
Q1 2021 May 13, 2021	BUY	$25.8 - $38.49 $29.6 Million - $44.1 Million	1,146,511 Added 27.06%	5,383,118 $192 Million
Q4 2020 Feb 12, 2021	BUY	$24.5 - $30.86 $104 Million - $131 Million	4,236,607 New	4,236,607 $119 Million

Others Institutions Holding MRVI

# of Institutions

174

Shares Held

130M

Call Options Held

426K

Put Options Held

37.5K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $354M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Maravai Lifesciences Holdings, Inc. Transaction History